Genomics

Dataset Information

0

Function and Mechanism of METTL5-mediated 18S rRNA m6A1832 modification in hepatocellular carcinoma


ABSTRACT: Tumor recurrence is main pattern of treatment failure for early-stage hepatocellular carcinoma (HCC). However, the molecular mechanisms underlying disease recurrence remain poorly understood. Here, we showed that 18S rRNA N6-methyladenosine (m6A1832) modification and its methyltransferase complex METTL5/TRMT112 were upregulated in HCC and correlated with poor prognosis. Loss-of-function and gain-of-function assays demonstrated that METTL5/TRMT112 mediated 18S rRNA m6A1832 modification promotes HCC tumorigenesis in vitro and in vivo. Mechanistically, 18S rRNA m6A1832 modification selectively regulated the translation of mRNAs with long 5’UTR and short 3’UTR through affecting the assembly of 80S subunit at translation initiation and its dissociation at translation termination which was executed by weakening the interaction of ABCE1 with eRF1 and eRF3. Moreover, METTL5-mediated 18S rRNA m6A1832 modification regulated β-oxidation of long-chain fatty acid through ACSL4 to promote HCC progression. Our work uncovered a novel layer of mRNA translation regulation mechanism at ribosome 80S subunit assembly and dissociation step mediated by 18S rRNA m6A1832 modification and revealed a new crosslink between RNA epigenetic modification and fatty acid metabolism in HCC.

ORGANISM(S): Homo sapiens

PROVIDER: GSE175827 | GEO | 2021/06/01

REPOSITORIES: GEO

Similar Datasets

2019-07-15 | GSE128699 | GEO
2020-04-15 | GSE144346 | GEO
2020-04-15 | GSE144313 | GEO
2022-02-13 | GSE186615 | GEO
| PRJNA528519 | ENA
2020-09-17 | GSE138123 | GEO
2023-04-19 | GSE223171 | GEO
2023-04-19 | GSE223169 | GEO
2023-04-19 | GSE223168 | GEO
2023-04-19 | GSE223167 | GEO